High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

被引:348
作者
Fredersdorf, S
Burns, J
Milne, AM
Packham, G
Fallis, L
Gillett, CE
Royds, JA
Peston, D
Hall, PA
Hanby, AM
Barnes, DM
Shousha, S
OHare, MJ
Lu, X
机构
[1] ST MARYS HOSP,IMPERIAL COLL SCH MED,LUDWIG INST CANC RES,LONDON W2 1PG,ENGLAND
[2] LUDWIG INST CANC RES,LONDON W1P 8BT,ENGLAND
[3] UNIV DUNDEE,DEPT MOL & CELLULAR PATHOL,DUNDEE DD1 9SY,SCOTLAND
[4] GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
[5] UNIV SHEFFIELD,SCH MED,DEPT PATHOL,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND
[6] CHARING CROSS HOSP,DEPT HISTOPATHOL,LONDON W6 8RF,ENGLAND
关键词
D O I
10.1073/pnas.94.12.6380
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The expression of cyclin-dependent kinase inhibitor p27(kip1) in human tumors and normal tissues was investigated using a panel of novel anti-p27(kip1) mAbs. An inverse correlation between expression of p27(kip1) and cell proliferation was generally observed after analyzing its expression in 25 different normal human tissues, In some highly proliferative human breast cancer cells, however, high level p27(kip1) expression was seen, indicating the existence of a mechanism by which some growing tumor cells may tolerate this inhibitor of cell cycle progression, Detailed studies demonstrated a correlation between the high level expression of p27(kip1) and cyclin D1 in human breast cancer cells. There was also an inverse correlation between the expression of p27(kip1) and the degree of tumor malignancy in human breast and colorectal cancers, indicating that p27(kip1) may be a useful prognostic marker in these cancers.
引用
收藏
页码:6380 / 6385
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]  
CLARKE C, 1994, EPITHELIAL CELL BIOL, V3, P38
[3]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[4]  
DEPOORTERE F, 1996, J CELL SCI, V108, P1759
[5]   MAMMALIAN G(1) CYCLINS [J].
DRAETTA, GF .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (06) :842-846
[6]   CDK INHIBITORS - ON THE THRESHOLD OF CHECKPOINTS AND DEVELOPMENT [J].
ELLEDGE, SJ ;
HARPER, JW .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (06) :847-852
[7]  
FERANDO AA, 1996, HUM GENET, V97, P91
[8]   A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice [J].
Fero, ML ;
Rivkin, M ;
Tasch, M ;
Porter, P ;
Carow, CE ;
Firpo, E ;
Polyak, K ;
Tsai, LH ;
Broudy, V ;
Perlmutter, RM ;
Kaushansky, K ;
Roberts, JM .
CELL, 1996, 85 (05) :733-744
[9]   INACTIVATION OF A CDK2 INHIBITOR DURING INTERLEUKIN 2-INDUCED PROLIFERATION OF HUMAN T-LYMPHOCYTES [J].
FIRPO, EJ ;
KOFF, A ;
SOLOMON, MJ ;
ROBERTS, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4889-4901
[10]  
Fredersdorf S, 1996, AM J PATHOL, V148, P825